Clinical Trials Logo

Recurrent or Persistent Endometrial Carcinoma clinical trials

View clinical trials related to Recurrent or Persistent Endometrial Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT02064725 Active, not recruiting - Clinical trials for Recurrent or Persistent Endometrial Carcinoma

Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA

Start date: September 2014
Phase: Phase 2
Study type: Interventional

This is an open label, multi-center, single arm phase II study. The study will investigate the efficacy of sodium cridanimod in conjunction with progestin therapy in a population of patients with recurrent or persistent PrR-negative endometrial cancer.